Related Laws Explorer

Equips first responders with epinephrine and allows bulk purchasing for municipalities.

Requires the New York State Department of Health to include Alpha-gal syndrome on the list of reportable tick-borne diseases to track its spread.

New York Asthma Inhaler Coverage Act (S.3100A)

S.3100A expands New York insurance coverage for the treatment of asthma to include a second rescue and maintenance inhaler, along with any medically necessary devices for children. New Yorkers with asthma can face large financial barriers to drugs that hinder optimal treatment; high out-of-pocket costs hinder adherence, threaten patient health, and exacerbate health disparities. The bill passed the Senate 59-2 on March 17, 2025 and was reported and committed to the Finance Committee on May 12, 2026.

New York bill S8587A requiring child day care centers to have epinephrine devices and staff trained to use them on site in case of anaphylaxis or other severe allergic reaction.

Permits trained non-medical individuals to possess and administer epinephrine.

Requires training for school personnel in treating severe allergies and anaphylaxis.

Prevents discrimination by insurers based on an individual's mental health or substance use disorder; incorporates into state law federal enforcement rules set forth in the federal Mental Health Parity and Addiction Equity Act of 2008.

Relates to establishing residential treatment facilities as an alternative to incarceration designated by the commissioner for the care and treatment of persons with serious mental illness who are accused of at least one felony level crime.

Stock Glucagon Bill

Proposes to allow designated entities, similar to the epinephrine and inhaler laws, to stock and administer glucagon for emergency treatment of severe hypoglycemia.

HB 2395

While focused on Naloxone, this recent legislative push reflects Oregon's policy trend toward allowing non-medical venues to stock emergency medications for respiratory failure. It serves as a legislative precedent for expanding mandatory stock epinephrine in public venues.

Virginia School Diabetes Care & Glucagon Law

Authorizes trained school employees to administer glucagon or insulin to students with diabetes during emergency hypoglycemic episodes when a school nurse is not available, and protects trained staff from civil liability.

Permits Idaho schools to maintain a stock of epinephrine auto-injectors and allows trained personnel to administer them to students experiencing anaphylaxis.

District of Columbia law or guidelines permitting schools to stock albuterol inhalers with a prescription and administer to students in respiratory distress.

Idaho law authorizing students with severe allergies to possess and self-administer prescribed epinephrine auto-injectors at school.

Requires school districts to maintain a supply of epinephrine auto-injectors and permits trained personnel to administer them to students experiencing anaphylaxis.

Allison Rose Act

The Allison Rose Act (Ohio HB 231) encourages school districts, community schools, and STEM schools to create food allergy training for staff members and students. Completed food allergy training by staff qualifies as a professional development activity for the renewal of educator licenses. The Act also helps individuals identify and respond to someone experiencing an allergic reaction, and requires the Ohio Department of Education (ODE) to compile an annual list of organizations that offer free epinephrine auto-injectors to qualifying school districts.

Stock Epinephrine on School Buses Bill

Proposed legislation that would require every school bus to be equipped with at least two stock epinephrine auto-injectors and require drivers to be trained in their use.

Prevents discrimination by insurers based on an individual's mental health or substance use disorder; incorporates into state law federal enforcement rules set forth in the federal Mental Health Parity and Addiction Equity Act of 2008.

Relates to establishing residential treatment facilities as an alternative to incarceration designated by the commissioner for the care and treatment of persons with serious mental illness who are accused of at least one felony level crime.